Using the information given below, calculate EBITDA. Assume the calculation of normalized EBIT includes typical normalizing adjustments. Assume the change in fair value of contingent consideration is not going to recur, and the impairment of assets charge is included in restructuring expenses. Assume the acquired in-process research and development was from a recent acquisition and is a one off expense. Net product sales 4,130.1 Other revenue 1.1 Total revenues 4,131.2 Cost of sales 374.3 Operating expenses: Research and development 730.4 Selling, general and administrative 1,111.8 Acquired in-process research and development 1,183.0 Amortization of purchased intangible assets 320.1 Change in fair value of contingent consideration 116.5 Acquisition-related costs Restructuring expenses 25.5 Impairment of intangible assets Total operating expenses 3.4873 Operating income 269.6 Other income and expense: Investment income 65.3 Interest expense (98.2) Other income and (expense) 5.5 Income before income taxes 242.2 Income tax expense 164.6 Net income 77.6 Cash flows from operating activities: Net income 77.6 Adjustments to reconcile net income to net cash flows from operating activities: Depreciation and amortization 4053 13.5 116.5 Impairment of assets Change in fair value of contingent consideration Payments of contingent consideration Share-based compensation expense Non-cash expense for acquired IPR&D Deferred taxes Unrealized foreign currency loss (gain) Unrealized (gain) loss on forward contracts Unrealized gain on equity investments Other Changes in operating assets and liabilities, excluding the effect of acquisitions: Accounts receivable Inventories Prepaid expenses and other assets Accounts payable, accrued expenses and other liabilities Net cash provided by operating activities 203.0 64.6 32.9 4.8 (15.8) (402) (2.0) (208.8) (14.7) (155.6) (55.1) 4260